These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19034695)

  • 1. The BLyS family: toward a molecular understanding of B cell homeostasis.
    Treml JF; Hao Y; Stadanlick JE; Cancro MP
    Cell Biochem Biophys; 2009; 53(1):1-16. PubMed ID: 19034695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulating B cell homeostasis: a key component in the advancement of targeted strategies.
    Treml LS; Quinn WJ; Treml JF; Scholz JL; Cancro MP
    Arch Immunol Ther Exp (Warsz); 2008; 56(3):153-64. PubMed ID: 18512030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice.
    Wilson NA; Bath NM; Verhoven BM; Ding X; Boldt BA; Sukhwal A; Zhong W; Panzer SE; Redfield RR
    Transplantation; 2019 Jul; 103(7):1372-1384. PubMed ID: 30830041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New roles for the BLyS/BAFF family in antigen-experienced B cell niches.
    Goenka R; Scholz JL; Sindhava VJ; Cancro MP
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):107-13. PubMed ID: 24507939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.
    Mackay F; Silveira PA; Brink R
    Curr Opin Immunol; 2007 Jun; 19(3):327-36. PubMed ID: 17433868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.
    Cancro MP
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii34-6. PubMed ID: 17038469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology. Lymphocyte survival--ignorance is BLys.
    Laâbi Y; Strasser A
    Science; 2000 Aug; 289(5481):883-4. PubMed ID: 10960320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of BAFF and APRIL in rheumatoid arthritis.
    Shabgah AG; Shariati-Sarabi Z; Tavakkol-Afshari J; Mohammadi M
    J Cell Physiol; 2019 Aug; 234(10):17050-17063. PubMed ID: 30941763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the study of BLyS and APRIL on regulating T cell responses in rheumatoid arthritis].
    Chang Y; Wei W
    Yao Xue Xue Bao; 2013 Jul; 48(7):979-85. PubMed ID: 24133964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.
    Treml LS; Crowley JE; Cancro MP
    Semin Immunol; 2006 Oct; 18(5):297-304. PubMed ID: 16919470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of BLyS action in B cell immunity.
    Do RK; Chen-Kiang S
    Cytokine Growth Factor Rev; 2002 Feb; 13(1):19-25. PubMed ID: 11750877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APRIL mediates peritoneal B-1 cell homeostasis.
    Sindhava VJ; Scholz JL; Stohl W; Cancro MP
    Immunol Lett; 2014 Aug; 160(2):120-7. PubMed ID: 24512739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.
    Do RK; Hatada E; Lee H; Tourigny MR; Hilbert D; Chen-Kiang S
    J Exp Med; 2000 Oct; 192(7):953-64. PubMed ID: 11015437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF and associated TNF superfamily members in renal transplantation: an end to BLySful ignorance.
    Chhabra M; Conlon TM; Saeb-Parsy K; Pettigrew GJ
    Transplantation; 2013 Nov; 96(10):853-9. PubMed ID: 23774811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.
    Smith SH; Haas KM; Poe JC; Yanaba K; Ward CD; Migone TS; Tedder TF
    Int Immunol; 2010 Aug; 22(8):681-91. PubMed ID: 20513733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B Cell-Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell-Dependent Bone Loss in Experimental Murine Periodontitis.
    Abe T; AlSarhan M; Benakanakere MR; Maekawa T; Kinane DF; Cancro MP; Korostoff JM; Hajishengallis G
    J Immunol; 2015 Aug; 195(4):1427-35. PubMed ID: 26150532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.
    Woodland RT; Fox CJ; Schmidt MR; Hammerman PS; Opferman JT; Korsmeyer SJ; Hilbert DM; Thompson CB
    Blood; 2008 Jan; 111(2):750-60. PubMed ID: 17942753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Space, selection, and surveillance: setting boundaries with BLyS.
    Miller JP; Stadanlick JE; Cancro MP
    J Immunol; 2006 Jun; 176(11):6405-10. PubMed ID: 16709796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease.
    Shi F; Xue R; Zhou X; Shen P; Wang S; Yang Y
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):666-673. PubMed ID: 34519594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
    Jelinek DF; Darce JR
    Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.